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. . . it challenges
logic that one could
obtain new accu-
rate information
from the quantita-
tive integration of
a number of very
diverse studies . . .he topic of meta-analysis has come up on several occasions during the weekly
meetings of the editors, and has provoked some spirited discussions. These
systematic reviews integrate and synthesize existing research studies in an
ttempt to derive new information by quantitative statistical analysis. We are quite
mpressed with the increasing number of such articles that we are receiving at JACC. A
uick check of PubMed confirmed that our experience is not unique. A search for the
eyword “meta-analysis” in PubMed yielded over 110 pages listing over 2,100 papers
ince January 1, 2008, while “meta-analysis and heart” alone accounted for over 130
rticles published in the first 6 months of this year. In fact, some articles are now being
evoted to meta-analysis of meta-analyses, so called meta-meta analysis (1). It seems
lear that we are experiencing a virtual explosion of this type of research activity.
There is no doubt that meta-analyses have many positive attributes (2,3). Busy physi-
ians have difficulty keeping abreast of the huge volume of medical literature, and some
ay not possess the analytic skills to resolve the often non-definitive or conflicting find-
ngs. Meta-analysis provides an attractive solution to this problem. By examining the
otality of data available about an issue, meta-analysis can identify inadequacies in exist-
ng data and point to areas of needed research, reduce the potential for erroneous find-
ngs occurring by chance, and more accurately define the benefit and possible adverse
ffects of management strategies. In fact, by combining smaller datasets, meta-analysis
ay establish unrecognized outcomes, may provide evidence of statistical significance
here it was previously absent, or may eliminate any possible bias in individual studies.
hile prospective randomized trials remain the highest level of clinical evidence, meta-
nalysis can provide generalizability that is often lacking in such protocols.
Having delineated its attributes, it must be acknowledged that meta-analysis carries
ome significant limitations. Primary among these, at least in my mind, is the total de-
endence upon the quality of the studies that are included. No amount of statistical ma-
ipulation can overcome defects in poorly conducted studies, a concept often expressed
s garbage in–garbage out. Heterogeneity among studies is another major limitation.
eterogeneity may involve the number and type of patients included, the location of the
tudy, the methods and/or equipment used, the experience of the investigators, the pres-
nce of additional medications, and other variables. Alternatively, the individual studies
ay differ in the results obtained. Obviously, the more homogeneous the findings of
ndividual reports, the greater the confidence in the results of integration. Meta-analysis
s very vulnerable to the effects of publication bias, or the tendency for studies with neg-
tive results to be less often submitted and accepted for publication than those with pos-
tive findings. Hopefully, the registration of clinical studies at their onset will help over-
ome this problem. Finally, meta-analysis is subject to the same potential bias of the
nvestigator and/or sponsor as are all research endeavors.
In addition to the above limitations, meta-analysis, like all investigation, is susceptibleo flaws in methodology. Accurate meta-analytic methodology requires that a compre-
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Editor’s Page July 15, 2008:237–8ensive literature search be performed and that strict cri-
eria for the exclusion of studies be provided. In general,
eta-analyses are graded on the quality of the data in-
luded, the quality of data extraction, the statistical meth-
dology used to combine data, and the degree to which
he limitations of the study are recognized and addressed.
espite these clearly delineated requirements, evidence
xists that meta-analyses are often performed imperfectly.
n fact, it has been reported that systematic reviews in
elds such as anesthesia, critical care, surgery, emergency
edicine, and others often contained deficiencies, and
hat 80% of such material published on asthma prior in
ne survey had major flaws (4). This may partially explain
hy individual meta-analyses on the same topic have been
ound to yield discordant results (5). Thus, in addition to
he limitations inherent in the technique, the validity of
he results may be compromised by suboptimal perfor-
ance of the study.
In view of the above it is not surprising that many in-
ividuals, including some JACC Editors, have been
oubtful about the value of meta-analysis. They are skep-
ical that separate studies involving different patients,
oming from different locations, and treated for dissimilar
ime periods according to diverse protocols, can yield any
eaningful results. A quip often heard from the skeptics
s that “meta-analysis is to analysis as metaphysics is to
hysics.” Even the advocates recognize that combining
pples and oranges carries the danger of sometimes result-
ng in a fruit salad. Nevertheless, there appears to be no
iminution in the enthusiasm for this type of investiga-
ion, and the manuscripts continue to arrive at a brisk
ace and to generally positive reviews.
As for myself, I have mixed feelings about meta-analy-
is. I recognize all of the attractive attributes of these sys-
ematic, quantitative reviews. No one can deny the value
f a paper that identifies the best data on a question, sub-
ects the extracted data to valid statistical analysis, and
ields a clear conclusion from the whole that was not es-
ablished by the individual studies. Such papers serve to
elp you keep up with the literature, and can provide the
oundation for evidence-based medical practice. I do
orry that such studies make it easy for me to be intellec-
ually lazy and not grapple with the source data myself,
ut this is not the fault of the study. However, I believe
5hat there are a limited number of settings where new,
alid, useful information can be derived by this technique.
he optimal situation exists when a reasonable number of
elatively well done, generally homogeneous randomized
rials exist that do not have adequate power to establish a
tatistically significant conclusion. Meta-analysis is of
esser value when only a few, small trials are available or
hen there are a substantial number of trials that all have
he same findings. Why do a meta-analysis if there is no
isparity in the data? There is a potential role for meta-
nalysis when multiple studies exist that have different
ndings. In this situation, however, the heterogeneity of-
en compromises accuracy and the issue is probably better
esolved by a large randomized clinical trial.
And so, despite its limitations, it is likely that we will
ontinue to receive an increasing number of meta-analy-
es. They are popular with readers, well received by re-
iewers, and increasingly used to define evidence-based
ractice and guidelines. Although it challenges logic that
ne could obtain new accurate information from the
uantitative integration of a number of very diverse stud-
es, the numerous meta-analyses published speak for
hemselves. Used in the proper setting, I think they can
ake a valuable contribution. The job of the Journal will
e to ensure that those published are in this setting and
re methodologically sound.
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